窄带成像与白光内镜诊断和监测Barrett食管的成本-后果模型数据集

数据集获取（Figshare）

• 源站标题：Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett’s esophagus: Cost-consequence model
• DOI：10.1371/journal.pone.0212916
• 发布日期：2019-03-13
• 文件数：2 个
• 文件总体积：29.73 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Economic_value_of_narrow-band_imaging_versus_white_light_endoscopy_for_the_diagnosis_and_surveillance_of_Barrett_s_esophagus_Cost-consequence_model/7838642

命令行下载

curl -L -o "pone.0212916.s001.docx" "https://ndownloader.figshare.com/files/14598254"
curl -L -o "pone.0212916.s002.docx" "https://ndownloader.figshare.com/files/14598257"

文件清单

• pone.0212916.s001.docx（14.45 KB）
• pone.0212916.s002.docx（15.29 KB）

文件总体积 29.73 KB（源站 API 实测）。

数据说明

Barrett’s esophagus (BE) is an abnormality arising from gastroesophageal reflux disease that can progressively evolve into a sequence of dysplasia and adenocarcinoma. Progression of Barrett’s esophagus into dysplasia is monitored with endoscopic surveillance. The current surveillance standard requests random biopsies plus targeted biopsies of suspicious lesions under white-light endoscopy, known as the Seattle protocol. Recently, published evidence has shown that narrow-band imaging (NBI) can guide targeted biopsies to identify dysplasia and reduce the need for random biopsies. We aimed to assess the health economic implications of adopting NBI-guided targeted biopsy vs. the Seattle protocol from a National Health Service England perspective. A decision tree model was developed to undertake a cost-consequence analysis. The model estimated total costs (i.e. staff and overheads; histopathology; adverse events; capital equipment) and clinical implications of monitoring a cohort of patients with known/suspected BE, on an annual basis. In the simulation, BE patients (N = 161,657 at Year 1; estimated annual increase: +20%) entered the model every year and underwent esophageal endoscopy. After 7 years, the adoption of NBI with targeted biopsies resulted in cost reduction of £458.0 mln vs. HD-WLE with random biopsies (overall costs: £1,966.2 mln and £2,424.2 mln, respectively). The incremental investment on capital equipment to upgrade hospitals with NBI (+£68.3 mln) was offset by savings due to the reduction of histological examinations (-£505.2 mln). Reduction of biopsies also determined savings for avoided adverse events (-£21.1 mln). In the base-case analysis, the two techniques had the same accuracy (number of correctly identified cases: 1.934 mln), but NBI was safer than HD-WLE. Budget impact analysis and cost-effectiveness analyses confirmed the findings of the cost-consequence analysis. In conclusion, NBI-guided targeted biopsies was a cost-saving strategy for NHS England, compared to current practice for detection of dysplasia in patients with BE, whilst maintaining at least comparable health outcomes for patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0212916（source: https://plos.figshare.com/articles/dataset/Economic_value_of_narrow-band_imaging_versus_white_light_endoscopy_for_the_diagnosis_and_surveillance_of_Barrett_s_esophagus_Cost-consequence_model/7838642）。